4-HO-Ept | 2595431-59-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 4-HO-Ept
• 英文别名: 3-[2-[ethyl(propyl)amino]ethyl]-1H-indol-4-ol
• CAS: 2595431-59-5
• 化学式: C₁₅H₂₂N₂O
• 分子量: 246.35
• InChiKey: JQELEPKHBXEAHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  39.3
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Methods of treating food allergy conditions
  申请人：Palo Alto Investors LP

  公开号：US11045454B2

  公开（公告）日：2021-06-29

  Methods for treating a subject for a food allergy condition are provided. Aspects of the methods include administering to a subject in need thereof a psychedelic agent in a manner effective to treat the subject for a food allergy condition. Effective administration of a psychedelic agent may include administering the psychedelic agent in an amount effective to treat the subject for the food allergy condition. In some instances, the subject is known to have a food allergy condition.

  本文提供了治疗食物过敏症的方法。这些方法的各个方面包括以有效治疗食物过敏症的方式向有需要的受试者施用迷幻剂。有效施用迷幻剂可包括以有效治疗受试者食物过敏症的量施用迷幻剂。在某些情况下，受试者已知患有食物过敏症。
• Methods of Treating Food Allergy Conditions
  申请人：Palo Alto Investors LP

  公开号：US20200179349A1

  公开（公告）日：2020-06-11

  Methods for treating a subject for a food allergy condition are provided. Aspects of the methods include administering to a subject in need thereof a psychedelic agent in a manner effective to treat the subject for a food allergy condition. Effective administration of a psychedelic agent may include administering the psychedelic agent in an amount effective to treat the subject for the food allergy condition. In some instances, the subject is known to have a food allergy condition.
• Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness
  申请人：Dresdner, JR. Karl P.

  公开号：US20200345585A1

  公开（公告）日：2020-11-05

  The invention relates to processes for making pharmaceutical aqueous therapeutic particles (AQTP) having stable exterior water clustering with nanosized thickness less than 300 nanometers, wherein the AQTP has an improved bioavailability when administered to a mammal compared to conventional pharmaceutical drug particles administered to the mammal. The invention relates to an improved process apparatus which is computer controlled, capable of continuous operation with high efficiency so as to make a more consistently acceptable AQTP compared to an previous prototype process apparatus of the Inventors. The invention provides compositions comprising of AQTP which comprise a substance selected from the group consisting of a cannabinoid such as CBD, a cell membrane pore-forming peptide such as PNC-27, a psychoactive drug, a pharmaceutical, a nutraceuticals, a mineral, an anion, a cation, a protein, a peptide, an amino acid, a polymer, a vitamins, an antioxidants, a fertilizer, a chemical, a medical use product, a medical kit use product, a personal consumer use product, a manufacturing use product, a energy use product such as a battery, and any combination thereof.
• METHODS OF TREATING MOOD DISORDERS
  申请人：Kruegel Andrew Carry

  公开号：US20220041551A1

  公开（公告）日：2022-02-10

  Methods of treating mood disorders with compounds disclosed herein. Also provided are pharmaceutical compositions that include those compounds.